GELS
Gelteq Limited Ordinary SharesNASDAQHealthcare$0.68+3.09%ClosedMarket Cap: $6.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.00
P/S
56.09
EV/EBITDA
-3.73
DCF Value
$-0.27
FCF Yield
-66.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-3317.7%
Net Margin
-4011.9%
ROE
-43.0%
ROA
-30.9%
ROIC
-27.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY 2025 | $165.6K | 100.0% | $-5.5M | $-6.6M | $0.00 | — |
| Q4 2024 | $0.00 | NaN% | $-966.6K | $-1.1M | $0.00 | — |
| FY 2024 | $0.00 | NaN% | $-2.9M | $-3.5M | $0.00 | — |
| Q3 2024 | $0.00 | NaN% | $-10.1M | $-727.4K | $0.00 | — |
| Q4 2023 | $-1.00 | 100.0% | $-833.4K | $-947.8K | $0.00 | — |
| FY 2023 | $79.8K | 38.7% | $-3.1M | $-3.5M | $-0.37 | — |
| Q4 2022 | $147.5K | 100.0% | $-1.0M | $-1.2M | $-0.13 | — |
| FY 2022 | $147.5K | 35.7% | $-3.2M | $-3.4M | $-0.36 | — |
| Q4 2021 | $0.00 | NaN% | $0.00 | $-233.4K | $-0.02 | — |
| FY 2021 | $0.00 | NaN% | $-647.6K | $-648.9K | $-0.07 | — |
| FY 2020 | $0.00 | NaN% | $0.00 | $-375.6K | $-0.16 | — |